The management of Type 2 diabetes: A survey of Australian general practitioners

M Jiwa; X Meng; D Sriram; J Hughes; Stephen Colagiuri; S.M Twigg; Timothy Skinner; T Shaw

doi:10.1016/j.diabres.2011.11.004

The management of Type 2 diabetes: A survey of Australian general practitioners

M Jiwa, X Meng, D Sriram, J Hughes, Stephen Colagiuri, S.M Twigg, Timothy Skinner, T Shaw

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: Toexplore how clinical and demographic variables impact on the management ofdiabetes mellitus in general practice.

Design: Astructured vignette survey was conducted in Australia. This included ninevignettes chosen at random from 128 developed around seven clinical variables.Respondents were asked to recommend a change in treatment and make specificrecommendations. A random sample of general practitioners (GPs) were recruited.Two diabetologists involved in the development of national guidelines alsoparticipated.

Results: 125(13.8%) GPs participated. Statistical analyses were used to generate outcomemeasures. GPs recommended a change in treatment for most (81.1%) cases; wereless likely to prescribe a statin (68.5% GPs vs.76.3% diabetologists), lesslikely to treat hypertension (66.7% vs.89%) and less likely to refer forlifestyle modification (82.3% vs. 96.5%). Significant disagreement occurredaround prescribing or changing oral hypoglycaemics. No GP characteristicsshowed significant impact. The proportion of GPs who agreed withdiabetiologists on dose and choice of drugs was 35.7% for statins, 49.6%forantihypertensives and 39.6% for oral hypoglycaemics.

Conclusions:There were significant differences between diabetologists and GPs on themanagement of diabetes. The survey suggestssignificant under-dosing by GPs.These findings warrant further investigation.

Original language	English
Pages (from-to)	326-332
Number of pages	7
Journal	Diabetes Research and Clinical Practice
Volume	95
Issue number	3
DOIs	https://doi.org/10.1016/j.diabres.2011.11.004
Publication status	Published - Mar 2012

Access to Document

10.1016/j.diabres.2011.11.004Licence: Unspecified

Cite this

@article{7550a2a32e624929b5371b2b26564985,

title = "The management of Type 2 diabetes: A survey of Australian general practitioners",

abstract = "Objective: Toexplore how clinical and demographic variables impact on the management ofdiabetes mellitus in general practice. Design: Astructured vignette survey was conducted in Australia. This included ninevignettes chosen at random from 128 developed around seven clinical variables.Respondents were asked to recommend a change in treatment and make specificrecommendations. A random sample of general practitioners (GPs) were recruited.Two diabetologists involved in the development of national guidelines alsoparticipated. Results: 125(13.8%) GPs participated. Statistical analyses were used to generate outcomemeasures. GPs recommended a change in treatment for most (81.1%) cases; wereless likely to prescribe a statin (68.5% GPs vs.76.3% diabetologists), lesslikely to treat hypertension (66.7% vs.89%) and less likely to refer forlifestyle modification (82.3% vs. 96.5%). Significant disagreement occurredaround prescribing or changing oral hypoglycaemics. No GP characteristicsshowed significant impact. The proportion of GPs who agreed withdiabetiologists on dose and choice of drugs was 35.7% for statins, 49.6%forantihypertensives and 39.6% for oral hypoglycaemics.Conclusions:There were significant differences between diabetologists and GPs on themanagement of diabetes. The survey suggestssignificant under-dosing by GPs.These findings warrant further investigation.",

author = "M Jiwa and X Meng and D Sriram and J Hughes and Stephen Colagiuri and S.M Twigg and Timothy Skinner and T Shaw",

year = "2012",

month = mar,

doi = "10.1016/j.diabres.2011.11.004",

language = "English",

volume = "95",

pages = "326--332",

journal = "Diabetes Research and Clinical Practice",

issn = "0168-8227",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - The management of Type 2 diabetes

T2 - A survey of Australian general practitioners

AU - Jiwa, M

AU - Meng, X

AU - Sriram, D

AU - Hughes, J

AU - Colagiuri, Stephen

AU - Twigg, S.M

AU - Skinner, Timothy

AU - Shaw, T

PY - 2012/3

Y1 - 2012/3

N2 - Objective: Toexplore how clinical and demographic variables impact on the management ofdiabetes mellitus in general practice. Design: Astructured vignette survey was conducted in Australia. This included ninevignettes chosen at random from 128 developed around seven clinical variables.Respondents were asked to recommend a change in treatment and make specificrecommendations. A random sample of general practitioners (GPs) were recruited.Two diabetologists involved in the development of national guidelines alsoparticipated. Results: 125(13.8%) GPs participated. Statistical analyses were used to generate outcomemeasures. GPs recommended a change in treatment for most (81.1%) cases; wereless likely to prescribe a statin (68.5% GPs vs.76.3% diabetologists), lesslikely to treat hypertension (66.7% vs.89%) and less likely to refer forlifestyle modification (82.3% vs. 96.5%). Significant disagreement occurredaround prescribing or changing oral hypoglycaemics. No GP characteristicsshowed significant impact. The proportion of GPs who agreed withdiabetiologists on dose and choice of drugs was 35.7% for statins, 49.6%forantihypertensives and 39.6% for oral hypoglycaemics.Conclusions:There were significant differences between diabetologists and GPs on themanagement of diabetes. The survey suggestssignificant under-dosing by GPs.These findings warrant further investigation.

AB - Objective: Toexplore how clinical and demographic variables impact on the management ofdiabetes mellitus in general practice. Design: Astructured vignette survey was conducted in Australia. This included ninevignettes chosen at random from 128 developed around seven clinical variables.Respondents were asked to recommend a change in treatment and make specificrecommendations. A random sample of general practitioners (GPs) were recruited.Two diabetologists involved in the development of national guidelines alsoparticipated. Results: 125(13.8%) GPs participated. Statistical analyses were used to generate outcomemeasures. GPs recommended a change in treatment for most (81.1%) cases; wereless likely to prescribe a statin (68.5% GPs vs.76.3% diabetologists), lesslikely to treat hypertension (66.7% vs.89%) and less likely to refer forlifestyle modification (82.3% vs. 96.5%). Significant disagreement occurredaround prescribing or changing oral hypoglycaemics. No GP characteristicsshowed significant impact. The proportion of GPs who agreed withdiabetiologists on dose and choice of drugs was 35.7% for statins, 49.6%forantihypertensives and 39.6% for oral hypoglycaemics.Conclusions:There were significant differences between diabetologists and GPs on themanagement of diabetes. The survey suggestssignificant under-dosing by GPs.These findings warrant further investigation.

U2 - 10.1016/j.diabres.2011.11.004

DO - 10.1016/j.diabres.2011.11.004

M3 - Article

VL - 95

SP - 326

EP - 332

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 3

ER -

The management of Type 2 diabetes: A survey of Australian general practitioners

Abstract

Access to Document

Fingerprint

Cite this